バイオプロセス容器市場-世界の産業規模、シェア、動向、機会、予測、容器タイプ別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

バイオプロセス容器の世界市場は、2024年に46億8,000万米ドルと評価され、予測期間中にCAGR22.57％で成長し、2030年までには158億7,000万米ドルに達すると予測されています。

市場の急拡大は、革新的な治療製品の開発をサポートする先進技術の導入と並んで、バイオ医薬品部門における自動化と機械学習の導入が増加していることが主な要因です。バイオプロセス容器は、医薬品製造において、従来のステンレス製システムに代わるコスト効率と信頼性の高いシステムとして機能します。シングルユースのデザインは、柔軟性を提供し、汚染リスクを軽減し、洗浄の必要性を最小限に抑えます。これらの容器は、その拡張性と操作効率の高さから、バイオ製造においてますます好まれるようになっています。最近の動向では、スマートセンサーやIoTベースの機能が統合され、バイオプロセス環境におけるプロセスのモニタリングと制御がさらに強化されています。

主要な市場促進要因

バイオ医薬品の研究開発と個別化医療の拡大

主要な市場課題

環境問題と廃棄物管理

主要市場動向

スマートテクノロジーとIoTの統合

目次

第1章 製品概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のバイオプロセス容器市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 容器タイプ別（2Dバイオプロセスコンテナ、3Dバイオプロセスコンテナ、その他のコンテナ・アクセサリ）
  • 用途別（上流工程、下流工程、プロセス開発）
  • エンドユーザー別（バイオ医薬品企業、ライフサイエンス研究開発企業、その他）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024年）
• 市場マップ
• 容器タイプ別
• 用途別
• エンドユーザー別
• 地域別

第6章 北米のバイオプロセス容器市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のバイオプロセス容器市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋のバイオプロセス容器市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のバイオプロセス容器市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのバイオプロセス容器市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界のバイオプロセス容器市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Saint-Gobain Group
• Lonza Group AG
• Avantor Funding Inc.
• Merck KGaA
• Sartorius AG
• CellBios Healthcare and Lifesciences Pvt Ltd.
• Cole-Parmer Instrument Co.
• Biomass Ventures Pte Ltd.

第16章 戦略的提言

第17章 調査会社について・免責事項

The Global Bioprocess Containers Market was valued at USD 4.68 billion in 2024 and is projected to reach USD 15.87 billion by 2030, growing at a CAGR of 22.57% during the forecast period. The market's rapid expansion is primarily driven by the increasing adoption of automation and machine learning within the biopharmaceutical sector, alongside the introduction of advanced technologies supporting the development of innovative therapeutic products. Bioprocess containers serve as a cost-efficient and reliable alternative to traditional stainless-steel systems in drug manufacturing. Their single-use design offers flexibility, reduces contamination risk, and minimizes cleaning requirements. These containers are increasingly favored in biomanufacturing due to their scalability and operational efficiency. Recent developments have also seen the integration of smart sensors and IoT-based functionalities, further enhancing process monitoring and control within bioprocessing environments.

Key Market Drivers

Expansion of Biopharmaceutical R&D and Personalized Medicine

The growing investment in biopharmaceutical research and personalized medicine is a major driver fueling demand for bioprocess containers. These containers, particularly single-use systems, offer key advantages such as reduced contamination risk, scalability, and operational flexibility-features essential for the evolving needs of biopharmaceutical production.

Significant funding initiatives are supporting this trend. In 2024, the U.S. National Institutes of Health (NIH) allocated over $47 billion to medical research, focusing on gene therapies and personalized treatments. Likewise, the European Union's Horizon Europe program earmarked €95.5 billion for innovation and health research between 2021 and 2027.

These investments are catalyzing the development of complex biologics, including monoclonal antibodies, cell therapies, and vaccines. Bioprocess containers play a vital role in this space, offering sterile, disposable solutions that help accelerate production timelines and reduce cross-contamination, thus supporting the efficient delivery of personalized medical solutions.

Key Market Challenges

Environmental Concerns and Waste Management

Despite operational advantages, the single-use nature of bioprocess containers presents a significant environmental challenge due to the generation of plastic-based biomedical waste. The disposal of these materials raises sustainability concerns across the biopharmaceutical industry.

Global regulatory bodies are placing increased emphasis on sustainable manufacturing. For example, the European Union has enacted directives to reduce plastic waste and promote recyclable or biodegradable alternatives. In the United States, the Environmental Protection Agency (EPA) is driving initiatives to manage plastic waste and encourage eco-friendly practices.

However, recycling bioprocess containers remains complex due to contamination risks and material limitations. The lack of standardized disposal protocols and viable recycling infrastructure makes it difficult for manufacturers to meet environmental compliance goals. As a result, the market faces mounting pressure to develop innovative materials and waste mitigation strategies that align with growing sustainability expectations.

Key Market Trends

Integration of Smart Technologies and IoT

The incorporation of smart technologies and IoT into bioprocess containers is transforming modern biomanufacturing. Smart containers equipped with real-time sensors and digital connectivity are enabling manufacturers to monitor critical process parameters such as temperature, pH, and pressure with high precision.

Governmental support for digital innovation in manufacturing is reinforcing this trend. The U.S. Department of Commerce's NIST and the European Commission's Industry 5.0 initiative both promote the adoption of intelligent systems to enhance industrial efficiency and adaptability.

This movement aligns with the broader evolution toward Industry 4.0, where automation, data analytics, and machine-to-machine communication are key drivers of operational excellence. Smart bioprocess containers enable predictive maintenance, improve traceability, reduce downtime, and support regulatory compliance-collectively enhancing product quality and manufacturing efficiency.

Key Market Players

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Saint-Gobain Group
• Lonza Group AG
• Avantor Funding Inc.
• Merck KGaA
• Sartorius AG
• CellBios Healthcare and Lifesciences Pvt Ltd.
• Cole-Parmer Instrument Co.
• Biomass Ventures Pte Ltd.

Report Scope:

In this report, the Global Bioprocess Containers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioprocess Containers Market, By Type of Containers:

• 2D Bioprocess Containers
• 3D Bioprocess Containers
• Other Containers and Accessories

Bioprocess Containers Market, By Application:

• Upstream Process
• Downstream Process
• Process Development

Bioprocess Containers Market, By End Users:

• Biopharmaceutical Companies
• Life Science R&D Companies
• Others

Bioprocess Containers Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioprocess Containers Market.

Available Customizations:

Global Bioprocess Containers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioprocess Containers Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 5.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 5.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.5. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Type of Containers
• 5.3.2 By Application
• 5.3.3 By End Users
• 5.3.4 By Region

6. North America Bioprocess Containers Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 6.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 6.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Bioprocess Containers Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Containers
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Bioprocess Containers Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Containers
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Bioprocess Containers Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Containers
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End User

7. Europe Bioprocess Containers Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 7.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 7.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Bioprocess Containers Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Containers
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Bioprocess Containers Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Containers
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Bioprocess Containers Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Containers
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Bioprocess Containers Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Containers
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Bioprocess Containers Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Containers
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End User

8. Asia-Pacific Bioprocess Containers Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 8.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 8.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Bioprocess Containers Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Containers
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End User
  • 8.3.2. India Bioprocess Containers Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Containers
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Bioprocess Containers Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Containers
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Bioprocess Containers Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Containers
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Bioprocess Containers Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Containers
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End User

9. South America Bioprocess Containers Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 9.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 9.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Bioprocess Containers Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Containers
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Bioprocess Containers Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Containers
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Bioprocess Containers Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Containers
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End User

10. Middle East and Africa Bioprocess Containers Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
  • 10.2.2. By Application (Upstream Process, Downstream Process, Process Development)
  • 10.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Bioprocess Containers Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Containers
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Bioprocess Containers Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Containers
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Bioprocess Containers Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Containers
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Bioprocess Containers Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Danaher Corporation
• 15.3. Saint-Gobain Group
• 15.4. Lonza Group AG
• 15.5. Avantor Funding Inc.
• 15.6. Merck KGaA
• 15.7. Sartorius AG
• 15.8. CellBios Healthcare and Lifesciences Pvt Ltd.
• 15.9. Cole-Parmer Instrument Co.
• 15.10. Biomass Ventures Pte Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer